Pipeline

MBF-118

MBF-118 is a potent and selective covalent partial agonist of the PPARg nuclear receptor, to be initially explored as a novel anti-fibrotic therapy.

MBF-015

MBF-015 is a novel and selective histone deacetylase 1/2 inhibitor for the treatment of neurodegenerative diseases.

MBF-362

MBF-362 is a dual antagonist of prostaglandin EP2/EP4 receptors as a novel immunotherapy for cancer treatment.

MBF-132

MBF-132 is a selective histone deacetylase 8 inhibitor for the treatment of fibrosis.

This website uses cookies so that you have the best user experience. If you continue browsing you are giving your consent for the acceptance of the mentioned cookies and the acceptance of our Cookies policy.
. ACEPTAR

Aviso de cookies